Article Text

other Versions

Systemic Lupus Erythematosus in a Multiethnic US Cohort (LUMINA) XXVII: Cytotoxic Therapy is an Additional Risk Factor for the Development of Symptomatic Osteonecrosis in Lupus Patients. Results of a Nested Matched Case-Control Study

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.